Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

AJMC
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

January 17th 2025

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.

AJMC
Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor

January 9th 2025

AJMC Q&A with Ian Neeland, MD | Background image credit: ipopba - stock.adobe.com
Overcoming Barriers to Guideline-Directed Cardiometabolic Care

January 1st 2025

FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes
FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

December 23rd 2024

FDA website | Image credit: Postmodern Studio – stock.adobe.com
FDA Rejects Sotagliflozin for Type 1 Diabetes; Lexicon Shifts Focus

December 20th 2024

More News

Pinar Gumus Balikcioglu, MD
July 22nd 2023

Rise in Pediatric Diabetes Cases Continued Through Year 2 of COVID-19 Pandemic

Patrick Campbell
An analysis of electronic health record data recorded from 2018-2022 within Duke University Medical Center–affiliated diabetes care centers suggests the increased rate of new-onset type 1 and type 2 diabetes observed during the first year of the pandemic persisted through 2022.
3D Line Graph | Image Credit: Marima – stock.adobe.com
July 20th 2023

Diabetes, CVD Mortality Increase After a Decade-Long Decline

Hayden E. Klein
While the overall age-adjusted mortality rate for diabetes and cardiovascular disease (CVD) declined between 1999 and 2019, researchers found an average annual 1% increase since 2014.
opened pill with coins falling out of it
July 14th 2023

Under Medicare Part D, $48 Billion Spent on Top 10 Drugs in 2021

Hayden E. Klein
According to a Kaiser Family Foundation analysis, 22% of Medicare Part D drug spending in 2021 went towards the 10 top-selling prescription drugs alone.
diabetes
July 5th 2023

New Research Suggests Differences in Diabetic Kidney Disease Between T1 and T2D

Hayden E. Klein
There may be significant differences in kidney disease between individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D).
Male and female doctors working on reports in medical office | Image Credit: lenetsnikolai – stock.adobe.com
June 26th 2023

Coordinated Care Significantly Improves Treatment Quality for Patients With T2D, Heart Disease

Hayden E. Klein
Late-breaking results of the COORDINATE-Diabetes trial were presented today at the American Diabetes Association (ADA) 83rd Scientific Sessions in San Diego, California.
Nurse, hands or technology for 3d globe networking, healthcare community or digital help in life insurance support. Zoom, medical or futuristic world for global hospital, woman or doctor on tablet ux | Image credit: C Malambo/peopleimages.com - stock.adobe.com
June 22nd 2023

Diabetes Prevalence Expected to Double Globally by 2050

Hayden E. Klein
New estimates predict that type 2 diabetes prevalence will more than double in the next 30 years, from 529 million people in 2021 to at least 1.3 billion in 2050.
FDA
June 21st 2023

FDA Approves Jardiance, Synjardy for Pediatric T2D

Hayden E. Klein
Yesterday’s FDA approvals of a new indication for empagliflozin and combination empagliflozin with metformin hydrochloride for pediatric type 2 diabetes (T2D) provide a new class of oral drugs to treat the condition in children.
person holding different pills in hand
June 13th 2023

Study Finds No Significant PK Effect of Coadministering Evogliptin With Empagliflozin or Dapagliflozin

Hayden E. Klein
Among a small cohort of healthy Korean male volunteers, evogliptin combined with empagliflozin or dapagliflozin had no significant effects on the pharmacokinetics (PK) of each drug.
courtroom gavel
June 7th 2023

Merck Files Lawsuit to Halt Medicare Drug Price Negotiations

Lauren Biscaldi, MS
According to a spokesperson, Merck is prepared to take the lawsuit to the Supreme Court as it challenges drug price negotiations as part of the Inflation Reduction Act.
Site Logo
June 5th 2023

Diabetes, Gaps in Care Coordination, and Preventable Adverse Events

Calvin L. Colvin, MSPH Oluwasegun P. Akinyelure, MD, MPH Mangala Rajan, MBA Monika M. Safford, MD April P. Carson, PhD Paul Muntner, PhD Lisandro D. Colantonio, MD, PhD Lisa M. Kern, MD, MPH
The authors examined the association of diabetes with self-reported gaps in care coordination and self-reported preventable adverse events using data from a national sample of older adults.
Amal Agarwal, DO, MBA
June 2nd 2023

Dr Amal Agarwal: Value-Based Contracts Can Help Align Incentives in Dialysis

Hayden E. Klein
Amal Agarwal, DO, MBA, chief clinical officer at Monogram Health, explains the importance of value-based agreements in dialysis care, and the issue of dialysis prevalence among low-income and marginalized communities.
Site Logo
June 2nd 2023

Stakeholder Analysis: Medicare Diabetes Prevention Program Awareness and Implementation

Melanie T. Turk, PhD, RN Natalie D. Ritchie, PhD Karen Jakub, PhD, RN
This article describes facilitators of and barriers to uptake of the underutilized Medicare Diabetes Prevention Program from the perspectives of health care providers and program suppliers in western Pennsylvania.
Site Logo
June 1st 2023

Economic Burden of Nonadherence to Standards of Diabetes Care

Marjan Zakeri, MD Benjamin D. Lewing, PhD Jennifer Contreras, MPH Sujit S. Sansgiry, PhD, MS
Using propensity score matching in a US nationally representative sample, authors found the effect of nonadherence to diabetes guidelines on health care expenditures of patients with diabetes.
patient sitting up in hospital bed
May 24th 2023

Diabetes Linked to Increased Mortality in Patients With COVID-19

Hayden E. Klein
A review of 24 meta-analyses supported the need for additional monitoring of patients with diabetes and COVID-19, especially if they have comorbidities associated with diabetes.
Bias Prejudice Discrimination Diversity Business Politics Employee Rights Concept: © wladimir1804 - stock.adobe.com
May 17th 2023

Researchers Uncover Potential Racial Biases in T2D Risk Prediction Models

Gianna Melillo
Authors offered specific recommendations for improving publishing and adoption of algorithmic processes focused on type 2 diabetes (T2D) going forward.
Doping Control Sports Analysis Test Laboratory. Medical concept on virtual screen: © WrightStudio - stock.adobe.com
May 11th 2023

Strategies to Improve Diabetes P4P Programs Should Consider Individual, Neighborhood Social Risks

Gianna Melillo
Knowledge is limited on the potential exclusion from pay-for-performance (P4P) programs of patients living with diabetes who have with individual or neighborhood social risks.
Roumie
May 8th 2023

Study: Adding GLP1RA to T2D Therapy Linked With Lower MACE In Older Patients Without CVD

Gianna Melillo
Study authors said the findings could inform clinicians when selecting therapies for patients with type 2 diabetes (T2D). However, an editorial found the follow-up period too short and differences between the study arms too small to be meaningful.
group of children sitting on ground
May 5th 2023

Youth Diabetes Risk Perception Not Associated With Engagement in Risk-Reducing Behaviors

Hayden E. Klein
Diabetes risk perception was linked to increased TV watching and 1 less day per week of at least 60 minutes of exercise, and was not associated with nutrition or weight loss attempts among adolescents.
Residential neighborhood: © arinahabich -stock.adobe.com
May 3rd 2023

Neighborhood Cohesion, Diabetes Prevalence Linked Across Demographic Groups

Jared Kaltwasser
Investigators said data show social factors are intertwined with health outcomes.
Paper with words diabetes type 2 and glasses | Image Credit: Vitalii Vodolazskyi - stock.adobe.com
April 28th 2023

Endoscopic Procedure May Eliminate Need for Insulin in Type 2 Diabetes

Hayden E. Klein
Researchers are beginning work on a double-blind randomized controlled trial to test the results of this preliminary study.
Mass testing for Covid-19 / SARS-CoV-2 infection concept: Several rapid antigen test kits. One kit in the middle showing a positive result (two lines visible) | Image Credit: Andreas Prott - stock.adobe.com
April 18th 2023

COVID-19 Linked to 3% to 5% Increase in Diabetes Incidence

Hayden E. Klein
The risk of incident diabetes was found to be 17% greater in individuals who had COVID-19, and it was higher among men and individuals with severe COVID-19.
man holding measuring tape around waist
April 12th 2023

How Bariatric Surgery Can Affect Diabetes Complications

Hayden E. Klein
The weight loss surgery may help reverse peripheral neuropathy and improve the stability of cardiovascular autonomic neuropathy and retinopathy in individuals with class II/III obesity.
Dr Robert Groves
April 11th 2023

Intriguing Possibilities Surround Expansion of Lifestyle Care Models, Says Dr Robert Groves

Justina Petrullo
Banner|Aetna's partnership with Virta and their diabetes reversal program brings to light the possibility for expansion to other health issues.
graphic of kidneys
April 7th 2023

Researchers Develop Predictive Model for Kidney Function Decline in Adults With T2D

Hayden E. Klein
Researchers developed a reliable prediction model for kidney function decline in adults with type 2 diabetes and early to moderately progressed chronic kidney disease, which was externally validated and made publicly available via a web-based application.
Dr Robert Groves
April 4th 2023

Dr Robert Groves Gives Overview of Results From Virta Diabetes Reversal Program

Justina Petrullo
Banner|Aetna has partnered with Virta and their diabetes reversal program, which now has data on outcomes and patient populations served so far.
Ring Binder with inscription Guidelines | Image Credit: tashatuvango – stock.adobe.com
March 30th 2023

How Updated Diabetes, Prediabetes Screening Guidelines Improve Access

Hayden E. Klein
The 2021 recommendations for diabetes and prediabetes screening led to a 14.8% proportionate increase in the total US population eligible for screening, compared with the 2015 guidelines.
Jeremy Wigginton, MD
March 27th 2023

Dr Jeremy Wigginton: Health Care Happens All the Time; Employers Need to Engage Their Population

Hayden E. Klein
For employers, keeping members engaged with their health care is one of the key factors that leads to better outcomes, said Jeremy Wigginton, MD, vice president of health quality and innovation at Blue Cross and Blue Shield of Louisiana.
pregnancy
March 25th 2023

Rising Gestational Diabetes Rates Could Be Result of Changes in Screening Practices

Patrick Campbell
An analysis of more than 500,000 pregnancies over a 15-year period suggests much of the increase in gestational diabetes rates observed during the study period can be attributed to changes in screening practices.
animation of head with brain and brainwaves
March 15th 2023

Co-occurring Diabetes and Tooth Loss Linked to Worse, Faster Cognitive Decline

Hayden E. Klein
New research suggests older adults with both diabetes and edentulism are more likely to experience worse and faster cognitive decline compared with adults without either condition and adults older in age.
Making Preventive Drugs Free Doesn’t Change Health Outcomes, Study Finds
March 6th 2023

Making Preventive Drugs Free Doesn’t Change Health Outcomes, Study Finds

Mary Caffrey
The findings of the ACCESS study show the complex challenge of improving medication adherence among the most fragile members of society.
<12345678
...
97>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo